1. Home
  2. OCTO vs IBO Comparison

OCTO vs IBO Comparison

Compare OCTO & IBO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OCTO
  • IBO
  • Stock Information
  • Founded
  • OCTO 1966
  • IBO 2018
  • Country
  • OCTO United States
  • IBO United States
  • Employees
  • OCTO N/A
  • IBO N/A
  • Industry
  • OCTO
  • IBO
  • Sector
  • OCTO
  • IBO
  • Exchange
  • OCTO Nasdaq
  • IBO NYSE
  • Market Cap
  • OCTO 4.4M
  • IBO 5.1M
  • IPO Year
  • OCTO N/A
  • IBO 2024
  • Fundamental
  • Price
  • OCTO $1.33
  • IBO $0.55
  • Analyst Decision
  • OCTO
  • IBO
  • Analyst Count
  • OCTO 0
  • IBO 0
  • Target Price
  • OCTO N/A
  • IBO N/A
  • AVG Volume (30 Days)
  • OCTO 159.6K
  • IBO 10.7M
  • Earning Date
  • OCTO 05-20-2025
  • IBO 05-23-2025
  • Dividend Yield
  • OCTO N/A
  • IBO N/A
  • EPS Growth
  • OCTO N/A
  • IBO N/A
  • EPS
  • OCTO 0.36
  • IBO N/A
  • Revenue
  • OCTO $39,621,272.00
  • IBO N/A
  • Revenue This Year
  • OCTO N/A
  • IBO N/A
  • Revenue Next Year
  • OCTO N/A
  • IBO N/A
  • P/E Ratio
  • OCTO $8.94
  • IBO N/A
  • Revenue Growth
  • OCTO N/A
  • IBO N/A
  • 52 Week Low
  • OCTO $0.98
  • IBO $0.37
  • 52 Week High
  • OCTO $4.86
  • IBO $6.17
  • Technical
  • Relative Strength Index (RSI)
  • OCTO 57.36
  • IBO N/A
  • Support Level
  • OCTO $1.24
  • IBO N/A
  • Resistance Level
  • OCTO $1.37
  • IBO N/A
  • Average True Range (ATR)
  • OCTO 0.12
  • IBO 0.00
  • MACD
  • OCTO 0.02
  • IBO 0.00
  • Stochastic Oscillator
  • OCTO 54.77
  • IBO 0.00

About OCTO Eightco Holdings Inc.

Eightco Holdings Inc operates in Forever 8 Inventory Cash Flow Solution. The company is a dynamic technology-focused company committed to driving growth and innovation through strategic acquisitions and management. Forever 8 focuses on purchasing inventory for e-commerce retailers and is part of its Inventory Solution Business.

About IBO IMPACT BIOMEDICAL INC

Impact BioMedical Inc focuses on the advancement of drug discovery and prevention, inhibition, and treatment of neurological, oncological, and immune-related diseases. The company is also developing open-air defense initiatives, which curb transmission of air-borne infectious diseases, such as tuberculosis and influenza. Its technologies inlcude Linebacker, Laetose, 3F, and Equivir.

Share on Social Networks: